Bullous pemphigoid secondary to bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1.

Wiggins, Claire J; Morris, Van K; Klimas, Natasha K; Nagarajan, Priyadharsini; Curry, Jonathan L; Richards, Kristen N.

Afiliação

Wiggins CJ; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Klimas NK; Department of Dermatology, The University of Texas Health Science Center at Houston, Houston, Texas.
Nagarajan P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Curry JL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Richards KN; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

JAAD Case Rep ; 13: 23-25, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34136620

Palavras-chave

BP, bullous pemphigoid; PD-1, programmed cell death-1; PD-L1, programmed cell death ligand-1; TGF-beta; TGF-ß, transforming growth factor beta; Treg, T regulatory cell; bintrafusp alfa; bullous pemphigoid; irAE, immune-related adverse events; programmed cell death ligand-1; programmed cell death receptor-1

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article